🇺🇸 FDA
Patent

US 11701394

Compositions and methods for treating cholestatic disease

granted A61KA61K31/58A61K35/74

Quick answer

US patent 11701394 (Compositions and methods for treating cholestatic disease) held by Seres Therapeutics, Inc. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/58, A61K35/74, A61K35/745, A61P